(NewsDirect)
New York, NY, May3rd, 2024 - ( 500NewsWire ) -- ETAO International Co., Ltd. (NASDAQ:ETAO) (“ ETAO ” or the“ Company ” ), a digital healthcare companyproviding medical care services, announced today that received adeficiency notice from Nasdaq that the Company is not in compliancewith the $2,500,000 minimum stockholders’ equity listing requirementset forth in Rule 5550(b)(1) because its Form 6-K for the period endedJune 30, 2023 filed with the SEC on March 8, 2024, reportedstockholders’ equity of $1,532,492. Additionally, as of the date ofthis Report, the Company does not meet the alternative Nasdaqcontinued listing standards under Nasdaq Listing Rules.
The Nasdaq HearingsPanel (the “ Panel ”) will consider this matter intheir decision regarding the Company’s continued listing on TheNasdaq Capital Market. Pursuant to Rule 5810(d), the Company isrequired to present its views with respect to this additionaldeficiency to the Panel in writing no later than May 3, 2024. In theevent the Company does not address this issue, the Panel will onlyconsider the record as presented at the hearing and will make itsdetermination based upon that information.
About ETAO International Group
ETAO InternationalGroup, a Cayman Islands company, aims to be the leading digitalhealthcare group providing telemedicine, hospital care, primary care,pharmacy, and health insurance covering all life stages of patients.ETAO became a public company listed in Nasdaq through merging withMountain Crest Acquisition Corp. III (MCAE) on Feb 21, 2023."ETAO" brand means "Best Medical Way" withtransformative medical care and unparalleled service. ETAO aims toprovide best-in-class internet medical services, such as artificialintelligence and big data technologies, to improve health caredelivery and quality in specialized clinics and hospital settings.ETAO's is in the process of building a platform that is seamlesslyintegrated based on its ability to combine technology and healthsciences.
ContactDetails
Wilson Liu
+1 347-306-5134
CompanyWebsite
Copyright (c) 2024 TheNewswire - All rights reserved.